0
0
0
0
1
2
3
$0
Is Microchip Technology solid or fragile? The Finex Financial Health Scanner reads MCHP's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2026) | $4.7B |
|---|---|
| Net income | $230.0M |
| Operating margin | 10.4% |
| Net margin | 4.9% |
| Cash and investments | $240.3M |
| Total debt | $5.5B |
| Free cash flow | $1.5B |
| Revenue growth (1 year) | 7.1% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.